Biochemical and Biophysical Research Communications, Vol.304, No.4, 708-713, 2003
In vivo processed fragments of IGF binding protein-2 copurified with bioactive IGF-II
Proteolysis of insulin-like growth factor binding proteins (IGFBPs), the major carrier of insulin-like growth factors (IGFs) in the circulation, is an essential mechanism to regulate the bioavailability and half-live of IGFs. Screening for peptides in human hemofiltrate, stimulating the survival of PC-12 cells, resulted in the isolation of C-terminal IGFBP-2 fragments and intact IGF-II coeluting during the chromatographic purification procedure. The IGFBP-2 fragments exhibited molecular masses of 12.7 and 12.9 kDa and started with Gly 169 and Gly 167, respectively. The fragments were able to bind both IGFs. The stimulatory effect of the purified fraction on the survival of the PC-12 cells could be assigned exclusively to IGF-II, since it was abolished by the addition of neutralizing IGF-II antibodies. We suggest that in the circulation IGF-II is not only complexed with intact IGFBP but also with processed IGFBP-2 fragments not impairing the biological activity of IGF-II. (C) 2003 Elsevier Science (USA). All rights reserved.
Keywords:hemofiltrate;insulin-like growth factor;IGF binding protein-2;cell viability;proteolysis;chromatography;RP-HPLC